External validation of chemotherapy response score system for histopathological assessment of tumor regression after neoadjuvant chemotherapy in tubo-ovarian high-grade serous carcinoma

OBJECTIVE: The chemotherapy response score (CRS) system based on histopathological examination has been recently proposed for tubo-ovarian high-grade serous carcinoma (HGSC) to assess response to neoadjuvant chemotherapy (NAC). This study was aimed at validating the CRS system in an external cohort...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jung-Yun, Chung, Young Shin, Na, Kiyong, Kim, Hye Min, Park, Cheol Keun, Nam, Eun Ji, Kim, Sunghoon, Kim, Sang Wun, Kim, Young Tae, Kim, Hyun-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641524/
https://www.ncbi.nlm.nih.gov/pubmed/28758379
http://dx.doi.org/10.3802/jgo.2017.28.e73

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641524/
https://www.ncbi.nlm.nih.gov/pubmed/28758379
http://dx.doi.org/10.3802/jgo.2017.28.e73

Ejemplares similares